| Mepha Pharma AG - Latanoprost-Mepha, Augentropfen |
| 60612 | | 01 | | Latanoprost-Mepha | | Augentropfen | | S01EE01 | | Latanoprost | | 12.10.2010 | | |
|
| Composition |
| latanoprostum 50 µg, natrii dihydrogenophosphas monohydricus et dinatrii phosphas corresp. phosphas 6.34 mg, natrii chloridum, aqua purificata, benzalkonii chloridum 0.2 mg, ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Collyre | | | | | | | | Principe actif | Concentr. |
|---|
| Latanoprost | 50 µg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Latanoprost | 50 mcg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Aqua Purificata | | | Benzalkonium Chlorure | 0.2 mg/ml | | Disodium Phosphate | | | Sodium Chlorure | | | Sodium Dihydrogenophosphate Monohydrate | |
| |
|
|
